PH18035A - Crystalline benzenesulfonate salts of sultamicillin - Google Patents

Crystalline benzenesulfonate salts of sultamicillin

Info

Publication number
PH18035A
PH18035A PH28804A PH28804A PH18035A PH 18035 A PH18035 A PH 18035A PH 28804 A PH28804 A PH 28804A PH 28804 A PH28804 A PH 28804A PH 18035 A PH18035 A PH 18035A
Authority
PH
Philippines
Prior art keywords
sultamicillin
benzenesulfonate salts
crystalline benzenesulfonate
crystalline
salts
Prior art date
Application number
PH28804A
Other languages
English (en)
Inventor
Wayne Ernest Barth
Vyrautas John Jasys
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PH18035A publication Critical patent/PH18035A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/28—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with modified 2-carboxyl group
    • C07D499/32—Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PH28804A 1982-04-23 1983-04-21 Crystalline benzenesulfonate salts of sultamicillin PH18035A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/371,156 US4432987A (en) 1982-04-23 1982-04-23 Crystalline benzenesulfonate salts of sultamicillin

Publications (1)

Publication Number Publication Date
PH18035A true PH18035A (en) 1985-03-06

Family

ID=23462725

Family Applications (1)

Application Number Title Priority Date Filing Date
PH28804A PH18035A (en) 1982-04-23 1983-04-21 Crystalline benzenesulfonate salts of sultamicillin

Country Status (27)

Country Link
US (1) US4432987A (enExample)
EP (1) EP0092968B1 (enExample)
JP (1) JPS58201792A (enExample)
KR (1) KR860001279B1 (enExample)
AU (1) AU536854B2 (enExample)
CA (1) CA1187484A (enExample)
CS (1) CS235320B2 (enExample)
DD (1) DD209632A5 (enExample)
DE (1) DE3362502D1 (enExample)
DK (1) DK162168C (enExample)
EG (1) EG16412A (enExample)
ES (1) ES8406075A1 (enExample)
FI (1) FI76092C (enExample)
GR (1) GR78582B (enExample)
HK (1) HK20588A (enExample)
HU (1) HU187068B (enExample)
IE (1) IE54628B1 (enExample)
IL (1) IL68453A (enExample)
NO (1) NO156202C (enExample)
NZ (1) NZ203988A (enExample)
PH (1) PH18035A (enExample)
PL (1) PL134978B1 (enExample)
PT (1) PT76587B (enExample)
SG (1) SG104087G (enExample)
SU (1) SU1138030A3 (enExample)
YU (1) YU43170B (enExample)
ZA (1) ZA832845B (enExample)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6621586A (en) * 1985-11-18 1987-06-02 University Of Texas System, The Polychelating agents for image and spectral enhancement (and spectral shift)
US5336762A (en) * 1985-11-18 1994-08-09 Access Pharmaceuticals, Inc. Polychelating agents for image and spectral enhancement (and spectral shift)
KR910009271B1 (ko) * 1989-06-20 1991-11-08 김영설 1,1-디옥소페닐실라노일 옥시메틸 D-6-[α-(메틸렌아미노)페닐-아세트아미도]-페니실라네이트와 그의 파라-톨루엔술폰산염
US6111098A (en) * 1994-05-02 2000-08-29 Shionogi & Co., Ltd. Crystal of pyrrolidylthiocarbapenem derivative, lyophilized preparation containing said crystal, and process for producing the same
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
PL374664A1 (en) 2002-08-29 2005-10-31 Taisho Pharmaceutical Co, Ltd. Benzenesulfonate of 4-fluoro-2-cyanopyrrolidine derivative
MXPA05010083A (es) * 2003-03-27 2005-11-23 Basilea Pharmaceutica Ag Cefalosporina en forma cristalina.
RU2006118801A (ru) * 2003-10-31 2007-12-10 Алза Корпорейшн (Us) Композиции и лекарственные формы для усиления всасывания габапентина и прегабалина
FR2877696B1 (fr) 2004-11-09 2009-09-18 Renault Sas Dispositif et procede d'estimation en temps reel de l'angle de debut de combustion d'un moteur a combustion interne
BRPI0815591B8 (pt) 2007-08-22 2021-05-25 Astrazeneca Ab composto, composição farmacêutica, e, uso de um composto.
TWI469971B (zh) 2007-10-26 2015-01-21 Univ California 二芳基乙內醯脲類化合物
NZ594064A (en) * 2009-01-30 2012-08-31 Glaxosmithkline Llc Crystalline n-{ (1s)-2-amino-1-[(3-fluorophenyl)methyl]ethyl} -5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride
TW201039825A (en) 2009-02-20 2010-11-16 Astrazeneca Ab Cyclopropyl amide derivatives 983
KR20120079054A (ko) * 2009-07-10 2012-07-11 에볼바 아게 디인 조성물
MX2012009537A (es) * 2010-02-18 2012-08-31 Astrazeneca Ab Formas solidas que comprenden un derivado de ciclopropilamida.
AU2011218491C1 (en) * 2010-02-18 2015-05-14 Astrazeneca Ab Processes for making cyclopropyl amide derivatives and intermediates associated therewith
JP6310396B2 (ja) * 2012-12-03 2018-04-11 株式会社カネカ 還元型補酵素ｑ１０誘導体およびその製造方法
TWI637943B (zh) * 2013-09-05 2018-10-11 田邊三菱製藥股份有限公司 新穎結晶性芳烷基胺化合物及其製造方法
PT3209647T (pt) 2014-10-21 2020-09-10 Ariad Pharma Inc Formas cristalinas de 5-cloro-n4-[2-(dimetilfosforil)fenil]-n2-{2-metoxi-4-[4-(4-metilpiperazin-1-il)piperidin-1-il]pirimidino-2,4-diamina
CN104958318A (zh) * 2015-08-04 2015-10-07 青岛蓝盛洋医药生物科技有限责任公司 一种治疗感染性疾病的药物舒巴坦钠组合物
WO2017125557A1 (en) * 2016-01-22 2017-07-27 Sandoz Ag Crystalline eravacycline bis-hydrochloride
EA039753B1 (ru) * 2016-07-07 2022-03-10 Сайклерион Терапьютикс, Инк. ТВЕРДЫЕ ФОРМЫ СТИМУЛЯТОРА sGC
EP3703686A4 (en) * 2017-10-30 2021-11-17 Theracaine LLC HYDROPHOBIC ARENE SULFONATE SALTS
US11186556B1 (en) * 2018-10-16 2021-11-30 Celgene Corporation Salts of a thiazolidinone compound, solid forms, compositions and methods of use thereof
UA119735C2 (uk) 2018-12-20 2019-07-25 Анатолій Семенович Редер Фармацевтична сполука, спосіб її отримання та застосування як лікарського засобу
USD1071069S1 (en) 2019-02-13 2025-04-15 Hs Produkt D.O.O. Stippled textured body for a firearm or the like
USD998740S1 (en) 2019-02-13 2023-09-12 Hs Produkt D.O.O. Firearm
USD1126349S1 (en) 2019-02-13 2026-05-12 Hs Produkt D.O.O. Firearm sight
USD994822S1 (en) 2019-02-13 2023-08-08 Hs Produkt D.O.O. Pistol
USD994821S1 (en) 2019-02-13 2023-08-08 Hs Produkt D.O.O. Pistol
USD1057880S1 (en) 2019-08-09 2025-01-14 Hs Produkt D.O.O. Pistol
CN117120034A (zh) * 2021-02-15 2023-11-24 普洛佩拉治疗公司 阿比特龙前药
CN117242070A (zh) * 2021-03-01 2023-12-15 奥仁公司 4h-吡喃-4-酮结构化cyp11a1抑制剂的固体形式
USD1049292S1 (en) * 2021-04-06 2024-10-29 Springfield, Inc. Pistol
JP7645573B2 (ja) * 2021-05-12 2025-03-14 ジャージアン・ロングチャーム・バイオ－テック・ファーマ・カンパニー・リミテッド ピロロピリミジン類化合物の結晶形およびその調製方法
BR112023021606A2 (pt) * 2021-05-14 2023-12-19 Global Blood Therapeutics Inc Formas sólidas de modulador de hemoglobina
US20240287066A1 (en) * 2021-06-24 2024-08-29 Sandoz Ag Crystalline Form of Sotorasib
USD1069964S1 (en) 2021-11-03 2025-04-08 Hs Produkt D.O.O. Pistol slide
WO2023125700A1 (zh) * 2021-12-28 2023-07-06 南京明德新药研发有限公司 四氢环庚吲唑化合物的盐型、晶型
IL314212A (en) * 2022-01-10 2024-09-01 Azafaros B V Treatment of GM2 gangliosidosis
CA3253725A1 (en) * 2022-05-20 2023-11-23 Caamtech, Inc. TRYPTAMINE DERIVATIVES
USD1057882S1 (en) 2022-08-29 2025-01-14 Springfield, Inc. Combined serrations for a firearm slide
USD1072997S1 (en) 2022-08-29 2025-04-29 Springfield, Inc. Firearm
USD1061781S1 (en) 2022-11-30 2025-02-11 Hs Produkt D.O.O. Pistol
US20240217985A1 (en) * 2022-12-22 2024-07-04 Boehringer Ingelheim International Gmbh CRYSTALLINE FORM OF AN MDM2-p53 INHIBITOR AND PHARMACEUTICAL COMPOSITIONS
ZAA202301171S (en) 2023-04-28 2024-09-25 Hs Produkt D O O Firearm
IL325861A (en) * 2023-07-17 2026-03-01 Kura Oncology Inc Crystalline forms of a menin inhibitor
JP2026525148A (ja) * 2023-07-17 2026-07-29 クラ オンコロジー，インク． メニン阻害剤を含む医薬組成物
USD1127974S1 (en) 2024-01-22 2026-05-26 Rost Martin LLC Firearm
USD1128830S1 (en) 2024-01-22 2026-06-02 Rost Martin LLC Firearm

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4234579A (en) * 1977-06-07 1980-11-18 Pfizer Inc. Penicillanic acid 1,1-dioxides as β-lactamase inhibitors
BE881675A (fr) * 1979-02-13 1980-08-12 Leo Pharm Prod Ltd B-lactames derives de l'acide penicillanique leur preparation et leurs utilisations therapeutiques
IE49880B1 (en) * 1979-02-13 1986-01-08 Leo Pharm Prod Ltd Penicillin derivatives
US4244951A (en) * 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
GB2084572B (en) * 1980-10-06 1984-07-11 Leo Pharm Prod Ltd 1,1-dioxopenicillanoyloxymethyl 6-(d-aphenylacetamido)penicillanate napsylate
IE51516B1 (en) * 1980-10-06 1987-01-07 Leo Pharm Prod Ltd 1,1-dioxapenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate napsylate
IL64009A (en) * 1980-10-31 1984-09-30 Rech Applications Therap Crystalline 1,1-dioxopenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate tosylate hydrates,their production and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
FI76092B (fi) 1988-05-31
FI76092C (fi) 1988-09-09
NO156202C (no) 1987-08-19
FI831392L (fi) 1983-10-24
EG16412A (en) 1989-03-30
GR78582B (enExample) 1984-09-27
ES521728A0 (es) 1984-07-01
ZA832845B (en) 1984-11-28
DK101783D0 (da) 1983-02-28
KR860001279B1 (ko) 1986-09-05
IL68453A0 (en) 1983-07-31
IL68453A (en) 1986-08-31
PL134978B1 (en) 1985-09-30
SG104087G (en) 1988-07-15
AU536854B2 (en) 1984-05-24
EP0092968B1 (en) 1986-03-12
CA1187484A (en) 1985-05-21
JPH0119395B2 (enExample) 1989-04-11
FI831392A0 (fi) 1983-04-22
CS235320B2 (en) 1985-05-15
IE830926L (en) 1983-10-23
PL241553A1 (en) 1983-11-21
DK101783A (da) 1983-10-24
HK20588A (en) 1988-03-25
KR840004437A (ko) 1984-10-15
YU43170B (en) 1989-04-30
SU1138030A3 (ru) 1985-01-30
US4432987A (en) 1984-02-21
DE3362502D1 (en) 1986-04-17
IE54628B1 (en) 1989-12-20
DK162168C (da) 1992-03-02
PT76587A (en) 1983-05-01
DD209632A5 (de) 1984-05-16
EP0092968A1 (en) 1983-11-02
HU187068B (en) 1985-11-28
NO831430L (no) 1983-10-24
NZ203988A (en) 1986-01-24
PT76587B (en) 1986-02-27
AU1387183A (en) 1983-11-17
YU90483A (en) 1986-04-30
DK162168B (da) 1991-09-23
JPS58201792A (ja) 1983-11-24
NO156202B (no) 1987-05-04
ES8406075A1 (es) 1984-07-01

Similar Documents

Publication Publication Date Title
DE3362502D1 (en) Crystalline benzenesulfonate salts of sultamicillin
GB8515980D0 (en) Mixture of salts
GB2128926B (en) Crystallisation of thermoplastic
AU562714B2 (en) Crystaline cephem-acid salts
YU42767B (en) Process for obtaining crystalline salts of benzothiazin-dioxide
DE3374305D1 (en) Process for the preparation of quaternary ammonium salts
GB8316168D0 (en) Crystalline gallosilicates
AU575137B2 (en) Crystalline ceftazidime salts
PT81274B (en) Process for the preparation of substituted 2-furanylalkoxyalkylcyclimmonium or 5-oxo-2-furanylalkoxyalkycyclimmonium salts
PT80999A (en) Process for the preparation of cyclimmonium salts
AU553252B2 (en) Crystalline salts of cefodizim
KE3785A (en) Crystalline benzenesulfonate salts of sultamicillin
DE3462139D1 (en) Process for the preparation of hydroxybenzylphosphonium salts
GB2158828B (en) Salts of fosfomycin
IL69566A0 (en) Crystallizable salts of a thiovinyl cephalosporin derivative and methods for the preparation of same
GB8406435D0 (en) Single crystalline dl-cysteine
EP0201055A3 (en) Process for the preparation of halogenide-free quaternary ammonium salts
GB8302317D0 (en) Crystalline form of sodium
GB8316589D0 (en) Crystalline salts
SU1075479A1 (ru) Выпарной аппарат для кристаллизации растворов
ZA843438B (en) Bis-alkylphosphonium salts of n-phosphonomethylglycine
GB8709633D0 (en) Crystalline compounds
PL237537A1 (en) Method of manufacture of crystalline microcellulose
GB8329750D0 (en) 5-phenoxybenzoic acid derivatives of pentites

Legal Events

Date Code Title Description
AT Record of annual fee payments

Year of fee payment: 12